about
sameAs
Ocular and central nervous system lymphoma: clinical features and diagnosisCD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans[Fainting after drinking a glass of whiskey-soda...].High levels of chromosome aberrations correlate with impaired in vitro radiation-induced apoptosis and DNA repair in human B-chronic lymphocytic leukaemia cells.Identical abnormality of the short arm of chromosome 18 in two Philadelphia-positive chronic myelocytic leukemia patients with erythroblastic transformation, resulting in duplication of BCR-ABL1 fusion.Concomitant heterochromatinisation and down-regulation of gene expression unveils epigenetic silencing of RELB in an aggressive subset of chronic lymphocytic leukemia in malesAcquired initiating mutations in early hematopoietic cells of CLL patients.Cytokine profile in human eyes: contribution of a new cytokine combination for differential diagnosis between intraocular lymphoma or uveitis.Cleaved lymphocytes in chronic lymphocytic leukemia: a detailed retrospective analysis of diagnostic features.B-cell chronic lymphocytic leukaemia: a polymorphic family unified by genomic features.Partial versus productive immunoglobulin heavy locus rearrangements in chronic lymphocytic leukemia: implications for B-cell receptor stereotypySpecific chromosomal IG translocations have different prognoses in chronic lymphocytic leukemia.Trisomy 4 associated with double minute chromosomes and MYC amplification in acute myeloblastic leukemia.Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies.IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma.A new phosphorylated form of Ku70 identified in resistant leukemic cells confers fast but unfaithful DNA repair in cancer cell lines.New molecular markers in resistant B-CLL.Changes in microrheology of acute promyelocytic leukemia cells during all-trans retinoic acid (ATRA) differentiation therapy: a mechanism for ATRA-induced hyperleukocytosis?Basket cells or shadow cells of Gumprecht: a scanning electron microscope study, and the correlation between percentages of basket cells, and cells with altered chromatin structure (dense cells), in chronic lymphocytic leukemia.[Automation in hematologic cytology]Apoptosis in blood diseases. Review new data.Caspase-independent type III programmed cell death in chronic lymphocytic leukemia: the key role of the F-actin cytoskeleton.STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model.A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia.Overview of available p53 function tests in relation to TP53 and ATM gene alterations and chemoresistance in chronic lymphocytic leukemia.Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study.Thrombospondin-1 Mimetic Agonist Peptides Induce Selective Death in Tumor Cells: Design, Synthesis, and Structure-Activity Relationship Studies.Seven new cases of hemoglobin Camperdown alpha 2 beta 2 104(G6)Arg----Ser found in Malta, Sicily and Tunisia.A new human mast cell line expressing a functional IgE receptor converts to tumorigenic growth by KIT D816V transfection.Impaired th1/tc1 cytokine production of tumor-infiltrating lymphocytes in a model of primary intraocular B-cell lymphoma.Mutagenicity of non-homologous end joining DNA repair in a resistant subset of human chronic lymphocytic leukaemia B cells.Functional assessment of p53 in chronic lymphocytic leukemia.Flow cytometry minimal residual disease after allogeneic transplant for chronic lymphocytic leukemia.Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway.Establishment and characterization of a new human erythroleukemic cell line, ERY-1.Functional analysis of human bone-marrow-and thymus-derived early T cells.What does apoptosis mean in CLL?Maturation of human myelomonocytic leukemia cells following ligation of the low affinity receptor for IgE (Fc epsilon RII/CD23).Drp1 mediates caspase-independent type III cell death in normal and leukemic cellsWaldenström's macroglobulinemia harbors a unique proteome where Ku70 is severely underexpressed as compared with other B-lymphoproliferative disorders.
P50
Q28206092-4EA27042-B218-49B0-99B7-509C5CC8430FQ28543785-77C9CB2B-1BCC-468B-8EDC-F5A2ECD68859Q33146274-5A662D44-2193-4E7A-9C79-D09AADE450FBQ33184199-D20E8B7D-0E41-4DCF-8D22-282D993A4E0FQ33185115-659FBA56-8133-473D-B584-95CC2B31D7A3Q33742884-ECA3F5D8-468F-4690-8E54-9768295752D4Q34424293-5D448AEC-785C-4E15-A639-100C0C4C8001Q34583801-877DAD47-1BE1-4237-A6BB-FB90DF93F840Q34632508-54552FE4-7E3E-421B-A723-D5959141A827Q35193688-752FEE58-00D1-4216-AF46-0FB9620ABF56Q35747546-2011EC75-A081-4413-A568-85D7CA4CEB2DQ35824945-5BDD4B9C-A9D0-44C6-9172-B6DF24C6896EQ35974584-5E3685F7-ACC4-4601-91A3-C56A4837A535Q36083000-7FC6530A-2207-45F4-B766-23FB9117AEEDQ36145665-B1603E71-6D5A-4249-A3DD-F8B2A86FD528Q36413959-B07282AA-C078-4264-8810-0A4B8451C93AQ36497411-0E5C06E0-18CC-4DCF-A62F-16FD8F1FC13FQ36692727-61F2F94B-5458-43EA-B513-06D05E20E47AQ36732938-918E63ED-71BD-49E3-9A71-DEBFF4562DEEQ36763833-1D0699E4-BD2C-40A6-A2AF-53298452784CQ36839382-C7BFCB9A-C2E0-4322-91DA-FDEC4C3157B1Q37146042-EBF46BE6-02F2-4A41-8B2D-D70FDD0A8DE8Q37273194-B81CCA74-23FB-40F4-BE0C-104F689C1BFBQ37625494-D58B3E21-E133-408A-8061-C4156E387DF5Q38101382-7B0E0F67-18CF-4E7A-9E85-159C4830D869Q38101382-A74CCF45-BEAD-4D4B-9370-963FB81B9052Q38270640-549B1791-6A6A-4BAF-BFAA-618D4D90169CQ38751770-22C1BDC9-4D18-417C-85F2-B7C992DADBD8Q38912214-FD8AE648-F490-471D-975C-D5A2334D6BE6Q39010730-C630137C-C224-4291-B966-184CE69B84BDQ40115348-B506F561-6E4C-4AC4-80F9-52FCCA84B6D7Q40282659-D04ED6B6-E342-42D2-B9CA-9062E24FB807Q40298340-1BC6C647-C4AB-4066-AF9E-F3149B6B166BQ40429099-5C1A8932-67A5-497C-A09A-335909285ECAQ40456980-83931668-A04F-442B-90E9-FE20CC6D9FB3Q40505919-4BF23D79-F1DE-4873-899C-DA817B12BF99Q40698908-8F956ECF-E2E5-4268-8AA4-3F8960EC81CFQ41342137-882B9032-BC26-4889-A752-B7E3AEA1D754Q41523687-235C8F5F-809A-4708-938F-283A53596F4BQ42059338-250C5E9F-AA8E-4B20-A9F8-CF5822E545AB
P50
description
chercheuse en médecine
@fr
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Hélène Merle-Béral
@af
Hélène Merle-Béral
@an
Hélène Merle-Béral
@ast
Hélène Merle-Béral
@bar
Hélène Merle-Béral
@br
Hélène Merle-Béral
@ca
Hélène Merle-Béral
@co
Hélène Merle-Béral
@cs
Hélène Merle-Béral
@cy
Hélène Merle-Béral
@da
type
label
Hélène Merle-Béral
@af
Hélène Merle-Béral
@an
Hélène Merle-Béral
@ast
Hélène Merle-Béral
@bar
Hélène Merle-Béral
@br
Hélène Merle-Béral
@ca
Hélène Merle-Béral
@co
Hélène Merle-Béral
@cs
Hélène Merle-Béral
@cy
Hélène Merle-Béral
@da
altLabel
Helene Merle-Beral
@en
prefLabel
Hélène Merle-Béral
@af
Hélène Merle-Béral
@an
Hélène Merle-Béral
@ast
Hélène Merle-Béral
@bar
Hélène Merle-Béral
@br
Hélène Merle-Béral
@ca
Hélène Merle-Béral
@co
Hélène Merle-Béral
@cs
Hélène Merle-Béral
@cy
Hélène Merle-Béral
@da
P214
P244
P268
P269
P106
P1412
P21
P213
0000 0001 3883 7162
P214
P244
n2017001854
P268
P269
P31
P3630
P496
0000-0002-7430-1143
P735
P7859
lccn-n2017001854